Canadian cannabis giant Aurora Cannabis Inc.(NASDAQ:ACB) (TSX:ACB) in conjunction with MedReleaf Australia, is launching its premium 1.2g resin cartridges in Australia. Now available for doctors to prescribe to patients in Australia, Aurora’s new resign cartridges, developed and manufactured at the company’s EU-GMP and TGA-GMP certified facility, will be distributed by MedReleaf Australia. “We are thrilled to bring premium resin cartridges to the Australian market, a signal of our commitment to expanding patient access to an even greater variety of premium cannabis,” stated Kristin Viccars, in…
